Injection of Glatiramer Acetate Depot Results in T1 and T2 Lesion Reduction in Relapsing MS.

Published Date: 01 Mar 2023

Secondary results from a phase 3 study show that patients with multiple sclerosis receiving glatiramer acetate depot therapy have significantly fewer new T1 enhancing lesions and new, enlarging hyperintense T2 lesions.

Read Full News

Latest News

What's Causing This Strange Constellation of Symptoms in an Older Woman?

Prompt assessment and treatment needed to prevent blindness, authors warn

What is Causing This MS Patient's Unusual Symptoms?

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

This Unusual Syndrome of the Face Could Be an Early Sign of AML

Case started with severe pain and numbness

New Autism Committee Chair Founded a Leucovorin Telehealth Company

Drug has been promoted as a treatment for autism

Possible Drug-Drug Interactions Flagged for Older Americans

— Many are on 5+ prescription drugs or dietary supplements

A Dementia Vaccine? Most Americans Say Yes

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Latest News

Prompt assessment and treatment needed to prevent blindness, authors warn

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

Case started with severe pain and numbness

Drug has been promoted as a treatment for autism

— Many are on 5+ prescription drugs or dietary supplements

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

News All Time

Controversial Neurologist to Lead NIH Unit; Hunter Trial Halted; Dads and Valproate

News and commentary from the world of neurology and neuroscience

More NFL Players Have CTE Than Previously Thought, Study Suggests

At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder

Federal Committee Looks Backward as Autism Science Moves Forward

In its second meeting, federal autism committee advances plan that may stymie promising research

New Migraine Prevention Guidance Highlights CGRP Drugs, Broad Eligibility

Guidelines from AAN and AHS get first update since 2012

Will Patient Deaths Derail the CAR-T Train in Autoimmune Disease?

Novartis, BMS reportedly halt trials; first serious blow to burgeoning field

Alzheimer's Genetic Risk; Underreported Dementia; Exercise or Nap After Sleep Loss?

News and commentary from the world of neurology and neuroscience

Study: Chronic Pain May Really Be 'All in Your Head'

Protein from skull bone marrow appears to play a key role

Autism-Vaccine Researcher Says He Stole $1M in CDC Grant Funds

Extradited Danish physician admits guilt in operating wire fraud scheme

Is Paxlovid Any Better Than Placebo for Long COVID?

In three major symptom phenotypes, randomized trial finds no benefit

1,081 Injuries Tied to Device; Military's COVID Shot Probe; Teen Vax Coverage Slides

Health news and commentary gathered by MedPage Today staff

Rare Brain Disorder Gets Its First FDA Drug Approval

Zilganersen targets protein buildup that drives Alexander disease

Parkinson's Risk and Carbon Monoxide: What a New Study Found

Analysis offers surprising twist to the smoking-Parkinson's puzzle

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

Recommended News For You

The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.

Chiauranib Slows Platinum-Resistant Ovarian Cancer

Mapping lifelong chronic health risks for childhood cancer survivors

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

Antibiotic Stewardship: Five Tips to Reduce Resistance

Study Warns on Venetoclax in Double-Hit Lymphoma

Sickle Cell Disease Drug Pulled From Global Markets

Recommended Articles For You

Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond 

Biomarkers of Treatment-Independent Functional Recovery in Cancer Survivorship 

Drug Safety Surveillance for Emerging Immuno-Oncology Medication Risks 

Case-Based Learning: Interpreting Unexpected Changes in Blood Counts During Longitudinal Clinical Follow-Up 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study shows virtual reality headsets may help ease cancer pain

2.

Understudied mental health challenges among caregivers of cancer patients: A call for targeted support

3.

Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know

4.

Review looks at potential treatment targets in the tumor microenvironment.

5.

Exercise can counter detrimental effects of cancer treatment, review suggests

1.

Understanding Granulosa Cell Tumors: Symptoms, Diagnosis, and Treatments"

2.

Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions

3.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

4.

Women's Cancer Survivorship: Emerging Long-Term Health Priorities

5.

Prognostic Trajectories of Functional Recovery Following Major Hematologic Disorders

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

3.

Understanding Anemia: Causes and Treatment

4.

From Guidelines to Practice: Hematology

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot